Creo Medical Group PLC (AIM:CREO)
London · Delayed Price · Currency is GBP · Price in GBX 13.88
+0.75 (5.71%)
Aug 15, 2025, 4:35 PM GMT+1
Creo Medical Group Market Cap
Creo Medical Group has a market cap or net worth of 55.84 million as of August 15, 2025. Its market cap has decreased by -43.81% in one year.
Market Cap
55.84M
Enterprise Value
51.54M
Revenue
4.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.88
Market Cap Chart
Since December 9, 2016, Creo Medical Group's market cap has decreased from 64.46M to 55.84M, a decrease of -13.36%. That is a compound annual growth rate of -1.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 55.84M | -28.79% |
| Dec 31, 2024 | 78.42M | -51.05% |
| Dec 29, 2023 | 160.20M | 255.34% |
| Dec 30, 2022 | 45.08M | -83.01% |
| Dec 31, 2021 | 265.37M | -13.37% |
| Dec 31, 2020 | 306.31M | 12.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.46B |
| GSK plc | 57.85B |
| Haleon | 32.21B |
| Smith & Nephew | 11.81B |
| ConvaTec Group | 4.73B |
| Hikma Pharmaceuticals | 4.01B |
| Oxford Nanopore Technologies | 2.11B |
| HUTCHMED (China) | 2.02B |